Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Clinical Trials on Poor Metabolizer Due to Cytochrome P450 CYP2C9 Variant in Canada
Total 0 results
Nothing found
Sponsors and Collaborators
Dr. Vivek Aggarwal
Acerus Biopharma Inc.
GlaxoSmithKline
Pei-Yuan Lee, MD
Metro North Hospital and Health Services
Sana Rouis
Sidney Kimmel Cancer Center at Thomas Jefferson University
Coalition Internationale Sida
farzaneh hojjat
Firstbeat Technologies Ltd.
The Danish Physiotherapy Foundation
Atos IT Solutions and Services Iberia
Shanghai Greenvalley Pharmaceutical Co., Ltd.
Zhuzhou Qianjin Pharmaceutical Co., Ltd., 801, Zhuzhou, China
Swim Across America Foundation
Hongguan biological pharmaceutical co.
Collèges Régionaux de Médecine Générale- CRMG - 18600 SANCOINS
Carol Davila University of Medicine and Pharmacy
IGEA
Società Italiana di Chirurgia Endoscopica e nuove tecnologie (SICE)
View Full List
Medical Conditions
Chronic Non Healing Wound
Osteoarthritis in the Hip, Knee and Hand
Leanness
CHOP
Cardiovascular Risk Score
Stage I Skin Melanoma
Discetomy
Steroids
Assessment of Skin Moisturization Factors
Distal Subungual Onychomycosis
Recurrent Carcinoma of the Vulva
Exploring Risk Assessment and Recovery From COVID-19 Infection in Hospitalised Patients
Sporadic Angiomyolipomas (AMLs)
Care Coordination in Primary Care
Schizoaffective
Colistin Resistance in Bacteria
Stage IVB Mycosis Fungoides and Sezary Syndrome
Landing Error Scoring System (LESS)
Insulin-like Growth Factor I
Femoral Head Collapse
View Full List
Drug Interventions
SPARC1104 modified dose regimen III
AUY922
TOCOSOL(R) Paclitaxel
[C-11]PiB-PET/MRI
Medium dose of BIBT 986 CL, per i.v. infusion
BH002
Standard treatment
B=Inhaled Alprazolam 0.5 mg
NDI-034858 study drug
5-FU
Rose Bengal
Paclitaxel (albumin-bound) combined with Oxaliplatin and S-1
R-metHuLeptin
Ezabenlimab
Insulin (Actrapid)
0.9% Sodium Chloride Injection
Doxophylline
Antiretroviral drugs
ITF2357
Citalopram
View Full List
CROs by country
Contract Research Organizations in Belgium
Contract Research Organizations in Dominican Republic
Contract Research Organizations in Ecuador
Contract Research Organizations in Egypt
Contract Research Organizations in Israel
Contract Research Organizations in Kazakhstan
Contract Research Organizations in Lithuania
Contract Research Organizations in Mauritania
Contract Research Organizations in Panama
Contract Research Organizations in Russia
Contract Research Organizations in Serbia
Contract Research Organizations in Spain
Contract Research Organizations in Switzerland
CRO list by country
CROs in Madagascar
SGS
All CROs in Madagascar
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe